FDA Covid-19 Update: Serological Test Validation and Education Efforts
The question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
Read MorePosted by | Apr 22, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
Read MorePosted by | Apr 22, 2020 | Controls, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Quality Systems |
The Qnostics SARS-CoV-2 Medium Q control is designed to ensure the accuracy and reliability of molecular assays used in diagnostic testing for covid-19.
Read MorePosted by | Apr 22, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Purdue’s animal disease diagnostic laboratory has received CLIA certification to conduct human diagnostic testing for covid-19.
Read MorePosted by | Apr 22, 2020 | Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases, Serology Instrumentation |
The Elecsys Anti-SARS-CoV-2 serology test will support the detection of antibodies against SARS-CoV-2 in patients who have been exposed to the virus.
Read MorePosted by | Apr 21, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The covid-19 test kit employs a single tube, and uses alveolar fluid, throat swab, or sputum samples to detect the virus, delivering results within hours.
Read More